Latest News of IMCR
Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now
The recent interest rate cut by the U.S. Federal Reserve has boosted stock market sentiments, with the Nasdaq 100 showing significant gains. The rate cut is expected to lower borrowing costs, benefitt...
Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy
The article discusses the performance of falling stocks such as Immunocore Holdings plc on the market. It highlights factors influencing stock performance, including fundamentals and market sentiment....
Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales
Immunocore Holdings plc (NASDAQ:IMCR) is a biotech company trading near its 52-week low despite solid financial performance. However, uncertainty over clinical trials and high short interest make it o...
-
Immunocore Holdings plc (IMCR): Short Seller Sentiment is Bearish on This Cancer Stock
By Yahoo! Finance | 1 month agoThe article discusses the growing significance of cancer in the healthcare sector, emphasizing the rise in global cancer cases and the advancements in oncology treatments....
-
Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds
By Yahoo! Finance | 2 months agoThe article discusses the benefits of diversifying investment portfolios with ADR stocks of foreign companies. Immunocore Holdings plc (NASDAQ:IMCR) is highlighted as a top ADR stock with significant ...